Before taking Ecoflox
Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start taking Ecoflox it is important that your doctor knows:
- If you are pregnant, trying for a baby, or breastfeeding.
- If you are under 18 years of age. This is because Ecoflox is only prescribed for children under the supervision of a doctor who is a specialist.
- If you have ever experienced a problem with your tendons, called tendonitis.
- If you have any problems with the way your k >
Rated Ecoflox (Cipro) for Diverticulitis Report
My muscles hurt so badly and my sodium levels dropped a lot. I felt like I was going to have a seizure. My fatigue was debilitating. I stopped Meds fearing what damage they were doing to me. I am still in muscle pain. Hard to walk. This needs to be removed from the market. Also was losing my brain functioning. Horrible horrible medication. Not sure if the generic made it worse or not BUT never again!!
Important: there are also a number of rare but more serious side-effects which have been associated with Ecoflox. Speak with your doctor as soon as possible if you experience any of the following:
- An allergic-type reaction, such as swelling around your face or mouth, a skin rash, or any difficulty breathing.
- Pain or inflammation in your muscles, tendons or joints (possible tendinopathy).
- Any feelings of pain, burning, tingling, numbness or weakness.
- Any problems with your vision or eyes, or changes to taste, smell or hearing.
If you experience any other symptoms which you think may be due to the medicine, speak with your doctor or pharmacist for advice.
Ecoflox S >
The most common side effects of Ecoflox are nausea, diarrhea, vomiting, and rash. Let your doctor know if you have any side effects.
Less common side effects include:
- Body aches
- Skin sensitivity to sunlight
- Loss of appetite
Serious side effects can also occur. If you have any of these side effects, stop taking Ecoflox and call your doctor right away or call 911:
- Unusual thoughts or hallucinations
- Depression or suic >Back to Top
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Clinical trials in patients with urinary tract infections enrolled 961 patients treated with 500 mg or 1000 mg CIPRO XR. The overall incidence, type and distribution of adverse reactions were similar in patients receiving both 500 mg and 1000 mg of CIPRO XR. The adverse reaction information from clinical studies does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates.
In the clinical trial of uncomplicated UTIs, CIPRO XR (500 mg once daily) in 444 patients was compared to Ecoflox immediate-release tablets (250 mg twice daily) in 447 patients for 3 days. Discontinuations due to adverse reactions thought to be drug-related occurred in 0.2% (1/444) of patients in the CIPRO XR arm and in 0% (0/447) of patients in the control arm.
In the clinical trial of cUTI and acute uncomplicated pyelonephritis (AUP) defined as infections occurring in premenopausal, non-pregnant women with no known urological abnormalities or comorbidities, CIPRO XR (1000 mg once daily) in 517 patients was compared to Ecoflox immediate-release tablets (500 mg twice daily) in 518 patients for 7 to 14 days. Discontinuations due to adverse reactions thought to be drug-related occurred in 3.1% (16/517) of patients in the CIPRO XR arm and in 2.3% (12/518) of patients in the control arm. The most common reasons for discontinuation in the CIPRO XR arm were nausea/vomiting (4 patients) and dizziness (3 patients). In the control arm the most common reason for discontinuation was nausea/vomiting (3 patients).
In these clinical trials, the following events occurred in ≥ 2% of all CIPRO XR patients: nausea (4%), headache (3%), dizziness (2%), diarrhea (2%), vomiting (2%) and vaginal moniliasis (2%).
Adverse reactions, judged by investigators to be at least possibly drug-related, occurring in greater than or equal to 1% of all CIPRO XR treated patients were: nausea (3%), diarrhea (2%), headache (1%), dyspepsia (1%), dizziness (1%), and vaginal moniliasis (1%). Vomiting (1%) occurred in the 1000 mg group.
Table 2: Medically Important Adverse Reactions That Occurred In